Literature DB >> 12130553

Deficiency of acyl coenzyme a:diacylglycerol acyltransferase 1 increases leptin sensitivity in murine obesity models.

Hubert C Chen1, Zuleika Ladha, Robert V Farese.   

Abstract

Acyl coenzyme A:diacylglycerol acyltransferase 1 (DGAT1) is one of two known enzymes that catalyze the final step in mammalian triglyceride synthesis. We have reported that DGAT1-deficient mice have increased insulin and leptin sensitivity, likely accounting for their protection against diet-induced obesity and insulin resistance. Here we show that DGAT1 deficiency enhanced the response to peripheral leptin infusion in Agouti yellow and leptin-deficient (ob/ob) mice, two genetic models of obesity and insulin resistance. Interestingly, DGAT1 deficiency did not enhance the response to intracerebroventricular leptin infusion. Moreover, DGAT1 deficiency did not alter the expression of key hypothalamic genes involved in leptin signaling or in the regulation of food intake and energy expenditure. Thus, the leptin-sensitizing effect of DGAT1 deficiency is present in both leptin-resistant and leptin-deficient genetic models of obesity and may occur in part by enhancing the effects of leptin in peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130553     DOI: 10.1210/endo.143.8.8941

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Fight fat with DGAT.

Authors:  Rinke Stienstra; Sander Kersten
Journal:  J Lipid Res       Date:  2011-01-28       Impact factor: 5.922

2.  Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats.

Authors:  Gudrun Schober; Myrtha Arnold; Susan Birtles; Linda K Buckett; Gustavo Pacheco-López; Andrew V Turnbull; Wolfgang Langhans; Abdelhak Mansouri
Journal:  J Lipid Res       Date:  2013-02-28       Impact factor: 5.922

Review 3.  Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism.

Authors:  Chi-Liang Eric Yen; David W Nelson; Mei-I Yen
Journal:  J Lipid Res       Date:  2014-09-17       Impact factor: 5.922

4.  Effects of DGAT1 deficiency on energy and glucose metabolism are independent of adiponectin.

Authors:  Ryan S Streeper; Suneil K Koliwad; Claudio J Villanueva; Robert V Farese
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-04-04       Impact factor: 4.310

5.  Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells.

Authors:  Megan M Robblee; Charles C Kim; Jess Porter Abate; Martin Valdearcos; Karin L M Sandlund; Meera K Shenoy; Romain Volmer; Takao Iwawaki; Suneil K Koliwad
Journal:  Cell Rep       Date:  2016-03-10       Impact factor: 9.423

6.  Obesity resistance and enhanced glucose metabolism in mice transplanted with white adipose tissue lacking acyl CoA:diacylglycerol acyltransferase 1.

Authors:  Hubert C Chen; Dalan R Jensen; Heather M Myers; Robert H Eckel; Robert V Farese
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 7.  Antilipidemic Drug Therapy Today and in the Future.

Authors:  Werner Kramer
Journal:  Handb Exp Pharmacol       Date:  2016

Review 8.  Genetic contributors to obesity.

Authors:  Ruth McPherson
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

9.  Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platform.

Authors:  Ahmed E Enayetallah; Daniel Ziemek; Michael T Leininger; Ranjit Randhawa; Jianxin Yang; Tara B Manion; Dawn E Mather; William J Zavadoski; Max Kuhn; Judith L Treadway; Shelly Ann G des Etages; E Michael Gibbs; Nigel Greene; Claire M Steppan
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

10.  Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in mice.

Authors:  Ryan S Streeper; Carrie A Grueter; Nathan Salomonis; Sylvaine Cases; Malin C Levin; Suneil K Koliwad; Ping Zhou; Mattew D Hirschey; Eric Verdin; Robert V Farese
Journal:  Aging (Albany NY)       Date:  2012-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.